SyAqua

Honolulu, United States Founded: 2001 • Age: 25 yrs Acquired By Ocean 14 Capital
Genomic selection services are offered for shrimp breeding enhancement.

About SyAqua

SyAqua is a Healthcare company based in Honolulu (United States) founded in 2001, and was acquired by Ocean 14 Capital in June 2022. Genomic selection services are offered for shrimp breeding enhancement. SyAqua has completed 1 acquisition, including Primo. SyAqua offers products and services including Genetics Solutions, Nutrition and Health Products, and Facilities Consulting. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is SyAqua Sdn Bhd. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.

Company details

SyAqua was established in 2001 by SyGen as a specific pathogen-free Penaeus vannamei shrimp breeding program. Based in Honolulu, United States, operations began at the University of California Berkeley, focusing on quantitative genetics. Best Linear Unbiased Prediction (BLUP) was pioneered for estimating breeding values without physical tagging. Since 2011, a genetic markers panel has been developed to identify genes linked to quantitative traits for parent selection in breeding candidates.

Key Metrics

Products & Services of SyAqua

SyAqua offers a comprehensive portfolio of products and services, including Genetics Solutions, Nutrition and Health Products, and Facilities Consulting.

Genetics Solutions
Genetic Development

Provides disease-resistant shrimp broodstocks for enhanced survival.

Nutrition and Health Products
Feed Solutions

Develops specialized shrimp larval nutrition for optimal growth.

Facilities Consulting
Farm Design Services

Offers advice on shrimp farm construction and management.

Investors in SyAqua

SyAqua has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ocean 14 Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in tech startups offering solutions to ocean sectors
ocean14capital.comLondon, United Kingdom
Premium access

Investor details for SyAqua

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SyAqua

3 people are tracked at SyAqua (3 in leadership).

NameRoleGroup
Fred H. Kao
Chief Executive OfficerLeadership
Wai Keong Wong
Finance Director, Gold Coin Syaqua Group (asia & Florida, Usa)Leadership
Adam Banaszak
Chief Commercial OfficerLeadership
Premium access

Complete people profiles for SyAqua

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SyAqua

SyAqua has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Primo.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Shrimp genetics services for disease-resistant Litopenaeus vannamei are provided.
primobroodstock.comMims, United States2000Jul 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for SyAqua

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of SyAqua

3 dated milestones of SyAqua across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded SyAqua is founded.
  2. Exit Acquired by Ocean 14 Capital.
  3. Acquisition Acquires Primo.

Competitors of SyAqua

SyAqua has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
Premium access

Detailed competitors of SyAqua

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as SyAqua (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Syaqua

Premium access

Complete news archive for SyAqua

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SyAqua

SyAqua was founded in 2001.

SyAqua is headquartered in Honolulu, United States. It is registered at Honolulu, Hawaii, United States.

SyAqua was established in 2001 by SyGen as a specific pathogen-free Penaeus vannamei shrimp breeding program. Based in Honolulu, United States, operations began at the University of California Berkeley, focusing on quantitative genetics. Best Linear Unbiased Prediction (BLUP) was pioneered for estimating breeding values without physical tagging. Since 2011, a genetic markers panel has been developed to identify genes linked to quantitative traits for parent selection in breeding candidates.

SyAqua's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.

SyAqua offers Genetics Solutions, Nutrition and Health Products, and Facilities Consulting.

SyAqua has made 1 acquisition, including Primo.

SyAqua has 1 investor. Key investors include Ocean 14 Capital.

SyAqua operates through Syaqua Sdn Bhd.

Yes. SyAqua was acquired by Ocean 14 Capital in June 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available